New appointments at Azbil Telstar: Jordi Puig as CEO and Emili Pablos, Executive Vice President & CFO

Azbil Telstar has announced the appointment of Jordi Puig as a Chief Executive Officer (CEO) and Emili Pablos as Executive Vice President & Chief Financial Officer (CFO) of the company. Jochen Dick, currently CEO of the company, will focus on his role of non-executive Vice Chairman of the Board of Directors of Azbil Telstar. Both appointments, which are effective on 31st July 2023, have been carried out after a transformation process from the integration of Telstar into the azbil Group. The appointment of Jordi Puig and Emili Pablos as Managing Directors of Azbil Telstar in April 2022 marked the beginning of the transition process towards a new structure of corporate governance and internal executive management of the business.

The decision has been taken after evaluating the positive impact of Telstar's transformation process on its integration into the corporate governance structure of the azbil Group since 2013, when Telstar moved from a family-owned structure to a corporate governance structure of a listed company. This process has been led by Jochen Dick since 2017 to reinforce the company's global strategic position and guarantee long-term sustainable growth.

After the acquisition process carried out by azbil Group in 2013, Azbil Telstar has been leading the Life Science Engineering business division of the Japanese corporation to provide global high-technology solutions in design, engineering, and manufacturing processes with automation technologies for the international life science markets. Throughout ten years of an evolution process of integration, the Telstar brand has consolidated its well-known reputation being acknowledged as one of the 10 major international innovative suppliers for the pharmaceutical industry, operating in over a hundred countries through its 11 subsidiaries around the world.

Azbil Telstar

Telstar is a leading global brand of aseptic process solutions. The company, part of the azbil Group, specializes in the development of highly complex projects, from integrated process equipment to design, engineering and construction of complete turnkey pharmaceutical and biotech production facilities, critical installations, clean rooms, and R&D laboratories.

Telstar invests 3% of its turnover in research, development and innovation of its technologies and equipment. The company operates in over a hundred countries and has 4 production plants, 6 technology centres and 10 consultancy and engineering services centres, and commercial offices all over the world. It has manufacturing plants in Spain, China and the United Kingdom. Headquartered in Terrassa (Barcelona, Spain), it has a workforce of 1,000 people.

Azbil

Azbil is a leading Japanese group in building automation for the building market, advanced automation for the industry market and life automation systems for the life sciences and healthcare markets as well as fields connected closely to everyday life. The group develops its own regulation, control and automation technologies, equipment, and systems for use in industry and in buildings.

As a subsidiary of Azbil, Telstar leads the Life Science Engineering business division of the Japanese corporation to provide global solutions in design, engineering, and manufacturing processes with automation technologies for the international life science markets, such as biopharmaceutical, life science research, personalized medicine, regenerative medicine, and functional foods.

Azbil Group, which is listed on the Tokyo stock exchange, was founded in 1906 and currently has a consolidated workforce of 10,063 people and a revenue of 278,4 million Yen in FY2022 (31/03/2023).

For more information:

TELSTAR
Phone: +34 93 736 16 00
Website: www.telstar.com
E-mail: pr@telstar.com